(Q36586088)

15 August 2017

1 reference

title

PET imaging of dopamine receptors in human basal ganglia: relevance to mental illness (English)

1 reference

emission computed tomography

15 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1695408

31 October 2022

author name string

G. Sedvall

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1695408

31 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1695408

31 October 2022

publication date

1 July 1990

1 reference

full work available at URL

15 August 2017

https://api.elsevier.com/content/article/PII:016622369090114P?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

https://api.elsevier.com/content/article/PII:016622369090114P?httpAccept=text/plain

31 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

31 October 2022

published in

Trends in Neurosciences

1 reference

15 August 2017

13

1 reference

15 August 2017

7

1 reference

15 August 2017

302-308

1 reference

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

15 August 2017

1

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

31 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

Antipsychotic drug doses and neuroleptic/dopamine receptors

31 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains.

31 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

Dopamine receptors and schizophrenia: drug effect or illness?

31 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

Positron emission tomography: human brain function and biochemistry

31 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

Imaging dopamine receptors in the human brain by positron tomography.

31 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

Imaging of neurotransmitter receptors in the living human brain

31 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

Positron emission tomography of the brain: new possibilities for the investigation of human cerebral pathophysiology.

31 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

Visualisation of 11C-flunitrazepam displacement in the brain of the live baboon

31 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

31 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

31 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis

31 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

Quantification of Neuroreceptors in the living human brain. II. Inhibition studies of receptor density and affinity.

31 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

[18F]-N-Methylspiroperidol: the radioligand of choice for PETT studies of the dopamine receptor in human brain.

31 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

Dopamine receptors displayed in living human brain with 77Br-p-bromospiperone.

31 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

31 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients.

31 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

No D2 receptor increase in PET study of schizophrenia

31 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain

31 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

3H-spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms

31 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.

31 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

31 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

Striatal binding of 11C-NMSP studied with positron emission tomography in patients with persistent tardive dyskinesia: no evidence for altered dopamine D2 receptor binding

31 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

Dopamine receptor subtype imbalance in schizophrenia

31 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

Human dopamine receptor subtypes--in vitro binding analysis using 3H-SCH 23390 and 3H-raclopride

31 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride.

31 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90114-P

31 October 2022

Identifiers

1 reference

15 August 2017

1 reference